Celsion Corporation (NASDAQ:CLSN)

CAPS Rating: 1 out of 5

A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.

Recs

0
Player Avatar pchop123 (79.78) Submitted: 1/14/2013 2:37:01 PM : Underperform Start Price: $40.59 CLSN Score: +16.98

A Pump & Dump with this much momentum should make a very loud noise when it finally Dumps!!!

Featured Broker Partners


Advertisement